2109. HHV-6 and EBV Reactivation after Allogeneic Hematopoietic Cell Transplantation in the Era of Letermovir for CMV Prophylaxis: A Retrospective Cohort Study

BACKGROUND: Letermovir (LTV) for CMV prophylaxis in allogeneic hematopoietic cell transplant (HCT) recipients has decreased utilization of broad-spectrum antivirals for CMV, which may result in more frequent reactivation of herpesviruses not targeted by LTV. We hypothesized that the cumulative incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Kampouri, Eleftheria, Krantz, Elizabeth M, Zamora, Danniel, Kimball, Louise E, Kiem, Erika, Lovas, Erika A, Blazevic, Rachel, Stevens-Ayers, Terry L, Huang, Meei-Li, Masumi, Ueda Oshima, Jerome, Keith R, Zerr, Danielle M, Boeckh, Michael J, Hill, Joshua A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752656/
http://dx.doi.org/10.1093/ofid/ofac492.1730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752656/
http://dx.doi.org/10.1093/ofid/ofac492.1730

Ejemplares similares